Clinical Trial Update: Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D [NA]

View source ↗

Summary

This completed clinical trial studied whether high-dose Vitamin D can modulate biomarkers associated with breast cancer risk. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Carol Fabian, MD | Conditions: Breast Cancer | NA | Status: COMPLETED | Results posted: 2014-03-10